Cargando…
Potential Mitochondrial Isocitrate Dehydrogenase R140Q Mutant Inhibitor from Traditional Chinese Medicine against Cancers
A recent research of cancer has indicated that the mutant of isocitrate dehydrogenase 1 and 2 (IDH1 and 2) genes will induce various cancers, including chondrosarcoma, cholangiocarcinomas, and acute myelogenous leukemia due to the effect of point mutations in the active-site arginine residues of iso...
Autores principales: | Lee, Wen-Yuan, Chen, Kuan-Chung, Chen, Hsin-Yi, Chen, Calvin Yu-Chian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066711/ https://www.ncbi.nlm.nih.gov/pubmed/24995286 http://dx.doi.org/10.1155/2014/364625 |
Ejemplares similares
-
Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014) -
Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants
por: Gao, Mingzhao, et al.
Publicado: (2019) -
Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer
por: Chen, Kuan-Chung, et al.
Publicado: (2014) -
In Silico Investigation of Potential TRAF6 Inhibitor from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014) -
Treatment of Cardiovascular Disease by Traditional Chinese Medicine against Pregnane X Receptor
por: Chen, Kuen-Bao, et al.
Publicado: (2014)